dulaglutide (Trulicity) -

dulaglutide (Trulicity)
Information type: Drug best practice guidance
Source: Scottish Medicines Consortium
Specialities: Diabetes | Endocrine system disorders
Summary
The SMC has accepted restricted use of dulaglutide within NHS Scotland, as add-on therapy with other glucose-lowering medicines including insulin, and diet and exercise, for adults with type 2 diabetes.
UKMi comment
It is restricted to use as part of triple therapy in patients with inadequate glycaemic control on two oral anti-diabetic drugs, as an alternative glucagon-like peptide 1 (GLP-1) agonist option.
Related links: